Positive results have been shared by pharmaceutical company MSD from their recent trial with Keytruda, combined with chemotherapy, as a promising treatment for high-risk early-stage triple negative breast cancer patients

The UK Charity for Triple Negative Breast Cancer is delighted to become a NICE stakeholder, contributing patient perspectives to the development of key breast cancer treatments.

The UK Charity for Triple Negative Breast Cancer is delighted to be announcing a Foundation to provide grants to fund further education for individual breast cancer nurses.

Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins Michal Sladkowski on the Let's Talk About SACT podcast. He discusses his experience with TNBC, the motivation behind the charity, and the support available for patients and staff.